Søgning
Søgning på udtrykket 'covid-19' giver 54 resultater
Dokumenter [9] Sider [3] Kalender [1] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [9]
Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Ændringer siden version 29: Indikationer for COVID-19 test er tilføjet.
COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed
Invitation til møde den 20. maj 2022
DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.
Virtuelt årsmøde med fokus på COVID-19 den 7. maj 2021
Afholdt fredag den 25. september 2020 som onlinemøde med fokus på COVID-19
Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale
Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.
Sider [3]
… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Behandling af COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2024v28), Post-COVID-19: Jacob Bodilsen, Christian Brandt, Stine Jo.
…diagnostiske undersøgelser ikke forsinke empirisk behandling ved symptomer herpå. Vaccinationer: Primær vaccination foretages mod Streptococcus pneumoniae, Haemophilus influenzae type B og Neisseria meningitidis. Årlig influenza-vaccination (samt COVID-19 vaccination ud fra aktuelle rekommandationer) anbefales på grund af øget risiko for sekundær bakteriel infektion. Pneumokokker. Den 20-valent konjugerede pneumokok vaccine, PCV20 (Apexxnar), anbefales til voksne.
Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid.
Kalender [1]
28. maj, Panum Instituttet, København
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
BMJ Open
9.05.2025
. Objectives. Explore what is known about the impact of changes made at a national level to UK postgraduate medical education during COVID-19. . Design. A scoping review, following Arksey and O’Malley’s framework, reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews Checklist. . Data sources. Ovid MEDLINE, Ovid Embase and ERIC were searched for peer-reviewed literature, and grey literature was searched via DuckDuckGo.
BMC Infectious Diseases
9.05.2025
…r mechanical ventilation progression. Given the link between delayed seroconversion and higher complication risks, we aim to test if evaluating SARS-CoV-2 spike protein antibody status before treatment could enhance IL-6 inhibitor therapy effectiveness in COVID-19 patients. . Methods.
PLoS One Infectious Diseases
8.05.2025
by Iris Delgado, Sushma Dahal, Maria I. Matute, Paola A. Rubilar Ramírez, Svenn-Erik Mamelund, Gerardo Chowell . The COVID-19 pandemic caused an unprecedented economic crisis, intensifying poverty levels in Latin America, particularly in Chile. This study examines the short- and long-term socioeconomic impacts of COVID-19 on income poverty in Chile, focusing on regional disparities, rurality, ethnicity, educational attainment, and immigration.
PLoS One Infectious Diseases
8.05.2025
by Mike Y. Chen, Jeanette Du, Brian K. Do, Mohsin H. Ali . Main objective Compare treatment outcomes of newly diagnosed neovascular age-related macular degeneration (nAMD) during and after the COVID-19 restrictions. Methods This retrospective study at the Retina Group of Washington analyzed nAMD patients treated with anti-VEGF therapy with ≥ 12 months of follow-up. Two groups were identified: 258 subjects diagnosed between March 2020-March 2022 (Group 1) and 376 subjects diagnosed after (Group 2).
International Journal of Infectious Diseases
8.05.2025
Since the emergence of the SARS-CoV-2, the virus responsible of COVID-19, in late 2019, there have been over 776 million reported cases and 7.07 million deaths worldwide as of December 10, 2024 [1]. While the overall incidence of COVID-19 has declined, some regions continue to report cases [1].
PLoS One Infectious Diseases
7.05.2025
…in, Md. Sakhawot Hossain . Background Inadequate dietary diversity is a significant challenge in public health for low-and middle-income countries, including rural communities in Bangladesh. These issues have intensified and become more tragic during the COVID-19 pandemic. This study evaluated the factors associated with household dietary diversity in rural Southwestern Bangladesh during the COVID-19 pandemic.
Journal of the American Medical Association
7.05.2025
This study examines post–COVID-19 pandemic cancer screening rates in 2023 relative to previously documented declines through 2021.
International Journal of Infectious Diseases
7.05.2025
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (Mtb), is a strictly airborne pathogen [1] and, until the COVID-19 pandemic, was the leading cause of death from all infectious diseases worldwide. It is increasingly being recognized that other respiratory infections, such as SARS-CoV-2 are also primarily transmitted by aerosols [1]. Airborne transmission is more likely in crowded indoor settings such as healthcare facilities.
BMJ Open
7.05.2025
. Objectives. To compare the incidence and drivers of major adverse kidney events (MAKEs) between COVID-19 and non-COVID-19 acute respiratory distress syndrome (ARDS) patients, with a focus on long-term kidney outcomes. . Design. Retrospective cohort study. . Setting. Single-centre intensive care unit in the Midlands, UK. . Participants. 708 ARDS patients (458 COVID-19, 250 non-COVID-19). . Primary and secondary outcome measures.
PLoS One Infectious Diseases
6.05.2025
…uent vaccination status. Subject and Methods In a sample of UK adults (n=1119) recruited through an online survey platform, vaccination intention was measured on a 0–10 numerical rating scale (0=very unlikely, 10=very likely) at the beginning of the UK COVID-19 vaccination rollout (January 2021), and self-reported vaccination status was gathered after vaccination had been offered to all adults (October 2021).
BMC Infectious Diseases
6.05.2025
. Background. Coronavirus 2019 (COVID-19) disease progression evidence and viral clearance time remain limited in tropical settings. Understanding this is crucial for public health control measures at community-level. We evaluated the viral dynamics of SARS-CoV-2 infection and factors associated with positivity duration in COVID-19 cases in Cameroon. . Material and Methods.
BMC Infectious Diseases
4.05.2025
…ath associated with bacterial superinfection in critically ill COVID-19 patients. We observed an increased risk of death for patients who developed a superinfection, with Enterobacterales being the predominant agent. The results emphasize the need for microbiological sampling in SARS-CoV-2-infected patients. . Clinical trial number. German Clinical Trials Register number: DRKS00031367, registration date: 01.03.2023 (drks.de/search/de/trial/DRKS00031367).
PLoS One Infectious Diseases
3.05.2025
by Katelyn Brehon, Pam Hung, Maxi Miciak, Winnie M. Leung, Kadija Perreault, Douglas P. Gross, Jason Weatherald, Paul E. Ronksley, Michael K. Stickland, Grace Y. Lam . Background The current study aimed to explore patient and provider perspectives of the impact of the pandemic on cystic fibrosis healthcare access and service delivery.
BMJ Open
3.05.2025
. Objectives. To monitor the safety and utilisation of AZD1222 under real-world use in the UK. . Design. A non-interventional post-authorisation active surveillance study. . Setting. Vaccination sites in the UK. . Participants. A total of 17 945 participants were eligible and provided consent to participate in the study between 1 March 2021 and 6 April 2023.
Virulence
3.05.2025
Volume 16, Issue 1, December 2025 .
AIDS
3.05.2025
We describe mortality in children living with HIV in Vietnam during the COVID-19 pandemic. We followed 1234 children (median age 11.9 years) at three hospitals during 2020–2023; 260 had COVID-19. Eleven (8.9%) children died, mostly due to poorly controlled HIV.
BMC Infectious Diseases
1.05.2025
. Background. The COVID-19 pandemic created a high demand for hospital beds and intensive care, which led to the collapse of healthcare systems. Therefore, it is critical to identify factors associated with increased mortality in patients to prioritize high-risk individuals. . Aim.
BMC Infectious Diseases
30.04.2025
. Background. Sepsis is a serious medical condition that causes long-term morbidity and high mortality, annually affecting millions of people worldwide. The COVID-19 pandemic may have impacted its burden. This study aimed to estimate the impact of the COVID-19 pandemic on sepsis incidence, etiology and associated hospitalization costs in metropolitan France. . Methods.
BMC Infectious Diseases
30.04.2025
. Background. Coronavirus disease 2019 (COVID-19) have posed a great threat to human health. We carried out this systematic review and meta-analysis for two objectives. First, to evaluate the differences in lung infection between the Omicron variants and the non-Omicron strains by chest computed tomography (CT); second, to evaluate the differences in chest CT features between COVID-19 patients with the Omicron variants and those with non-Omicron strains in CT-positive cases.
BMC Infectious Diseases
30.04.2025
. Background. Post COVID-19 condition (PCC) affects 10–40% of patients and is characterized by persisting symptoms at ≥ 4 weeks after SARS-CoV-2 infection. Symptoms can last 7 or even more months. How long PCC persists and any changes in its clinical phenotypes over time require further investigation. We investigated PCC trajectories and factors associated with PCC persistence. . Material and methods.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
9.05.2025
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 vaccine recommendations for the upcoming immunization. . Reuters Health Information
Medscape Infectious Diseases
1.05.2025
China restated its case that COVID-19 may have originated in the United States in a white paper on its pandemic response released on Wednesday after President Donald Trump's. . Reuters Health Information
Medscape Infectious Diseases
30.04.2025
Pope Francis’ health crisis highlights the delicate balance between transparency and privacy, particularly if COVID-19 had been involved and the global reaction it could have provoked. . Medscape UK
Statens Serum Institut
25.04.2025
Nyt dansk studie viser, at de opdaterede covid-19-vacciner fortsat beskytter effektivt mod alvorlig sygdom og død – også over for nye virusvarianter.
Morbidity and Mortality Weekly Report (MMWR)
25.04.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
ProMED
13.04.2025
…ttp://www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Thu 10 Apr 2025 . Source: CIDRAP (Center for Infectious Disease Research & Policy). [edited] . www.cidrap.umn.edu/covid-19/using-study-design-past-researchers-again-show-covid-19-airborne . . . In 1959, researchers built a facility near Pretoria, South Africa, to. study the airborne route of tuberculosis transmission, replicating an.
Medscape Infectious Diseases
8.04.2025
New research links multisystem inflammatory syndrome in children with COVID-19 to Epstein-Barr virus reactivation, revealing immune dysfunction and potential treatment targets. . Medscape Medical News
Medscape Infectious Diseases
4.04.2025
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's COVID-19 vaccine, the company told Reuters on. . Reuters Health Information
ProMED
2.04.2025
…******************************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . In this update: . [1] Russia: Publication of daily COVID-19 reports halted . [2] Macau: COVID-19 positive rate at 40%; 2 health bureaus urge. vaccination . [3] Hong Kong: Local influenza activity continues to decline, COVID-19. activity begins to rise slightly .
Morbidity and Mortality Weekly Report (MMWR)
1.04.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
ECDC COVID-19 updates
26.03.2025
COVID-19 vaccination reduced the risk of developing ‘long COVID’ by approximately 27% in adults fully vaccinated before infection, according to a literature review carried out by the European Centre for Disease Prevention and Control (ECDC).
ECDC COVID-19 updates
26.03.2025
This report addresses whether COVID-19 vaccination also reduces the risk and/or duration of a wide range of post-acute COVID-19 symptoms, commonly referred to as ‘long COVID’.
ECDC COVID-19 updates
22.03.2025
ECDC is supporting a large number of targeted External Quality Assessment (EQA) schemes with voluntary participation by reference or primary laboratories, which are active members of EU surveillance networks.
Medscape Infectious Diseases
19.03.2025
After COVID-19, RSV cases appear earlier and result in more severe illness in infants, with increased oxygen and ventilation needs, a new study reports. . Medscape News UK
Medscape Infectious Diseases
14.03.2025
Daily oral drug reduced COVID-19 risk by 67% in exposed but uninfected adults . Medscape Medical News
Eurosurveillance latest updates
14.03.2025
. Background. Evolution of SARS-CoV-2 is continuous. . . Aim. Between 01/2020 and 02/2022, we studied SARS-CoV-2 variant epidemiology, evolution and association with COVID-19 severity. . . Methods. In nasopharyngeal swabs of COVID-19 patients (n = 1,762) from France, Italy, Spain, and the Netherlands, SARS-CoV-2 was investigated by reverse transcription-quantitative PCR and whole-genome sequencing, and the virus variant/lineage (NextStrain/Pangolin) was determined.
Medscape Infectious Diseases
12.03.2025
Adjusted odds ratio showed similar prevalence of long COVID in cancer survivors and controls. . Medscape Medical News
ECDC COVID-19 updates
11.03.2025
This protocol presents an updated common methodology for estimating COVID-19 vaccine effectiveness (VE) using established health data registries in participating European Union (EU) and European Economic Area (EEA) Member States.
Medscape Infectious Diseases
11.03.2025
Early administration of high-titre COVID-19 convalescent plasma prevents hospitalisation and death in immunocompromised patients with mild COVID-19. . Medscape News UK
ProMED
9.03.2025
…********************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . In this update: . [1] Selected regions . [A] Hong Kong: JN.1 COVID-19 vaccine to replace the XBB vaccine for. infants and children . [B] New Zealand (Tairāwhiti/Gisborne): First COVID-19 death of 2025. recorded . [2] Another bat virus discovered from China: What makes HKU5-CoV-2. different from COVID-19 .